Search Results

An Interview With Dierk Scheinert, MD

The LINC course director and dedicated trial investigator discusses the evolution of the LINC meeting, therapies for difficult peripheral cases, and some of the novel technologies currently being studied.

An Interview With Dierk Scheinert, MD

The LINC course director and dedicated trial investigator discusses the evolution of the LINC meeting, therapies for difficult peripheral cases, and some of the novel technologies currently being studied.

Drug-Eluting Balloons in the SFA

Dierk Scheinert, MD, discusses the THUNDER and FemPac trial results and previews new studies that will evaluate drug-coated balloons versus plain old balloon angioplasty.

Update: Drug-Eluting Stents in Tibial Arteries

Two-year results from the Leipzig Cypher BTK registry.

By Dierk Scheinert, MD

Do the TASC Guidelines Still Apply?

Current available data suggest that an adjustment may be necessary.

By Dierk Scheinert, MD

Techniques for Crossing Iliac and Aortoiliac CTOs

Using access strategies and reentry devices for successful intervention.

By Dierk Scheinert, MD, and Andrej Schmidt, MD

Preliminary Experience With DESs in Tibial Arteries

Sirolimus-eluting stents appear to be safe and effective in treating focal infrapopliteal obstructions.

By Dierk Scheinert, MD; Giancarlo Biamino, MD; and Andrej Schmidt, MD

Excimer Laser Treatment of SFA Occlusions

The combination of excimer laser technology with current interventional devices and advanced recanalization techniques offers certain advantages over standard PTA techniques.

By Giancarlo Biamino, MD, and Dierk Scheinert, MD

Percutaneous Deep Venous Arterialization

A brief technical overview of a new therapy for treating end-stage “no-option” critical limb ischemia.

By Steven Kum, MD; Yih Kai Tan, MD; Tjun Tang, MD; Andrej Schmidt, MD; Dierk Scheinert, MD; and Roberto Ferraresi, MD

EVAR in 3D: The Leipzig Experience

Exploring the role of three-dimensional printing in preprocedural planning and custom fenestration in physician-modified grafts to treat acute, complex abdominal and thoracoabdominal aortic pathologies.

By Daniela Branzan, MD; Andrej Schmidt, MD, PhD; Dirk Winkler, MD, PhD; Dierk Scheinert, MD, PhD; and Ronny Grunert, PhD

Bioresorbable Stent Technology for Femoropopliteal Disease Treatment: Where Do We Stand?

Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.

By Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD

Industry Consolidation's Potential Effects on Meetings and Physician Education

Endovascular Today asked for perspectives from leading conference organizers by posing the question, “To what degree are you concerned about how industry consolidation could affect support for vascular meetings and physician education?”

With Gary M. Ansel, MD; Barry T. Katzen, MD; Dierk Scheinert, MD; Roger M. Greenhalgh, MD; Sean P. Lyden, MD; and Frank J. Veith, MD